Non-surgical treatment of benign paroxysmal positional vertigo (BPPV) - a randomised controlled trial of procedures and practices

ISRCTN ISRCTN84087880
DOI https://doi.org/10.1186/ISRCTN84087880
Secondary identifying numbers N0256111276
Submission date
12/09/2003
Registration date
12/09/2003
Last edited
19/10/2011
Recruitment status
Stopped
Overall study status
Stopped
Condition category
Signs and Symptoms
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr R Palaniappan
Scientific

Audiological Medicine Department, RNTNE
Royal Free Hampstead NHS Trust
330 Grays Inn Road
Kings Cross
London
WC1X 8DA
United Kingdom

Phone +44 020 7915 1300 ext 4259
Email rudipal@hotmail.com

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeNot Specified
Scientific title
Study objectivesHow efficient are the different non-surgical treatments that are in current clinical practice? Is any one method better than the other?
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedSigns and Symptoms: Benign paroxysmal positional vertigo (BPPV)
Intervention1. Particle repositioning manoeuvre alone
2. Particle repositioning manoeuvre plus soft collar & sleeping instructions
3. Particle repositioning manoeuvre with bone vibrator
4. Particle repositioning manoeuvre with bone vibrator plus soft collar & sleeping instructions
5. Control group treated with rehabilitation exercises
Intervention typeOther
Primary outcome measureAll the above described methods are recognized standard treatment procedures for BPPV in current clinical practice. Patients will be reviewed in the clinic 8 weeks post-treatment, when they will be required to answer the Dizziness Handicap Inventory (DHI). Questionnaire. A negative Hallpike's test during this visit would be considered as a positive outcome.
Secondary outcome measuresNot provided at time of registration
Overall study start date01/02/2002
Completion date31/07/2003
Reason abandoned (if study stopped)Poor recruitment

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target number of participants100
Key inclusion criteriaOutpatients who have a positive Dix-Hallpike's positional test diagnostic of BPPV
Five groups, approx 20 patients per group. 5 Patients recruited 2001- 2002.
Key exclusion criteriaNot provided at time of registration
Date of first enrolment01/02/2002
Date of final enrolment31/07/2003

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Audiological Medicine Department, RNTNE
London
WC1X 8DA
United Kingdom

Sponsor information

Department of Health (UK)
Government

Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Website http://www.doh.gov.uk

Funders

Funder type

Government

The Royal Free Hampstead NHS Trust (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan